DIXON HUBARD FEINOUR & BROWN INC/VA - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 131 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2017. The put-call ratio across all filers is 1.81 and the average weighting 0.0%.

Quarter-by-quarter ownership
DIXON HUBARD FEINOUR & BROWN INC/VA ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q1 2021$50,0000.0%19,6480.0%0.01%
-53.8%
Q4 2020$50,0000.0%19,6480.0%0.01%0.0%
Q3 2020$50,000
-15.3%
19,6480.0%0.01%
-13.3%
Q2 2020$59,000
+22.9%
19,6480.0%0.02%
-6.2%
Q1 2020$48,000
-48.4%
19,6480.0%0.02%
-33.3%
Q4 2019$93,000
+10.7%
19,6480.0%0.02%
+4.3%
Q3 2019$84,000
-27.0%
19,6480.0%0.02%
-30.3%
Q2 2019$115,000
+51.3%
19,6480.0%0.03%
+43.5%
Q1 2019$76,000
+105.4%
19,6480.0%0.02%
+64.3%
Q4 2018$37,000
-41.3%
19,6480.0%0.01%
-17.6%
Q3 2018$63,000
+6.8%
19,6480.0%0.02%0.0%
Q2 2018$59,000
-23.4%
19,6480.0%0.02%
-19.0%
Q1 2018$77,000
-4.9%
19,6480.0%0.02%
-4.5%
Q4 2017$81,000
-51.8%
19,648
-28.3%
0.02%
-54.2%
Q3 2017$168,000
-1.2%
27,3920.0%0.05%
-2.0%
Q2 2017$170,000
-2.3%
27,3920.0%0.05%
-5.8%
Q1 2017$174,000
+18.4%
27,3920.0%0.05%
+10.6%
Q4 2016$147,000
-4.5%
27,3920.0%0.05%
-2.1%
Q3 2016$154,000
-13.5%
27,392
-15.4%
0.05%
-15.8%
Q2 2016$178,000
-30.2%
32,3920.0%0.06%
-31.3%
Q1 2016$255,000
-5.2%
32,3920.0%0.08%
-3.5%
Q4 2015$269,000
-7.6%
32,392
+0.4%
0.09%
-19.6%
Q3 2015$291,000
+47.7%
32,276
+96.7%
0.11%
+75.4%
Q2 2015$197,00016,4100.06%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q4 2017
NameSharesValueWeighting ↓
Third Security, LLC 9,709,607$60,394,0003.07%
MSD Partners, L.P. 3,410,500$21,213,0001.32%
MILLER VALUE PARTNERS, LLC 4,926,456$30,643,0001.24%
Michael & Susan Dell Foundation 66,749$415,0000.33%
ACUTA CAPITAL PARTNERS, LLC 150,000$933,0000.26%
Piermont Capital Management Inc. 85,500$532,0000.15%
A.R.T. Advisors, LLC 411,547$2,559,0000.14%
EQUITEC PROPRIETARY MARKETS, LLC 96,100$598,0000.14%
Vident Investment Advisory, LLC 204,744$1,274,0000.10%
EQUITEC PROPRIETARY MARKETS, LLC 68,800$428,0000.10%
View complete list of ZIOPHARM ONCOLOGY INC shareholders